PT2182954T - Utilização de ácidos nor-biliares no tratamento de arteriosclerose - Google Patents

Utilização de ácidos nor-biliares no tratamento de arteriosclerose

Info

Publication number
PT2182954T
PT2182954T PT08775321T PT08775321T PT2182954T PT 2182954 T PT2182954 T PT 2182954T PT 08775321 T PT08775321 T PT 08775321T PT 08775321 T PT08775321 T PT 08775321T PT 2182954 T PT2182954 T PT 2182954T
Authority
PT
Portugal
Prior art keywords
arteriosclerosis
treatment
bile acids
bile
acids
Prior art date
Application number
PT08775321T
Other languages
English (en)
Inventor
Fickert Peter
Tarek Moustafa
Trauner Michael
Original Assignee
Univ Graz Medizinische
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Graz Medizinische filed Critical Univ Graz Medizinische
Publication of PT2182954T publication Critical patent/PT2182954T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
PT08775321T 2007-07-25 2008-07-24 Utilização de ácidos nor-biliares no tratamento de arteriosclerose PT2182954T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95172807P 2007-07-25 2007-07-25
EP07113107 2007-07-25

Publications (1)

Publication Number Publication Date
PT2182954T true PT2182954T (pt) 2019-02-06

Family

ID=39744896

Family Applications (1)

Application Number Title Priority Date Filing Date
PT08775321T PT2182954T (pt) 2007-07-25 2008-07-24 Utilização de ácidos nor-biliares no tratamento de arteriosclerose

Country Status (7)

Country Link
US (2) US20100311708A1 (pt)
EP (1) EP2182954B1 (pt)
ES (1) ES2709489T3 (pt)
PT (1) PT2182954T (pt)
SI (1) SI2182954T1 (pt)
TR (1) TR201901012T4 (pt)
WO (1) WO2009013334A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2468762A1 (en) 2010-11-30 2012-06-27 Dr. Falk Pharma Gmbh Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
EP3461485A1 (en) * 2017-09-28 2019-04-03 Dr. Falk Pharma Gmbh Use of nor-ursodeoxycholic acid for reducing liver fat
WO2021130232A1 (en) 2019-12-23 2021-07-01 Medizinische Universität Wien Bile acid derivatives in the medical intervention of anxieties and/or stress symptoms

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892868A (en) * 1984-08-17 1990-01-09 Gipharmex, S.P.A. Derivatives of biliary acids, process for the production thereof and corresponding pharmaceutical compositions
IT1255449B (it) * 1992-06-30 1995-10-31 Fabio Berlati Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
TW289020B (pt) * 1993-05-08 1996-10-21 Hoechst Sktiengesellschaft
IL123998A (en) * 1998-04-08 2004-09-27 Galmed Int Ltd Conjugates of bile salts and pharmaceutical preparations containing them
IL142650A (en) * 1998-04-08 2007-06-03 Galmed Int Ltd Use of bile acid conjugates or bile salts and fatty acids or fatty acids in the preparation of pharmaceuticals for lowering cholesterol, for the treatment of fatty liver and for the treatment of hyperglycemia and diabetes
US7312208B2 (en) * 2002-08-28 2007-12-25 Asahi Kasei Pharma Corporation Quaternary ammonium compounds
PL1890705T3 (pl) * 2005-05-12 2016-05-31 Univ Graz Medizinische Zastosowanie 24-nor-UDCA do leczenia cholestatycznych chorób wątroby
US20070116755A1 (en) * 2005-11-22 2007-05-24 Zadini Filiberto P Dissolution of arterial cholesterol plaques by pharmacological preparation

Also Published As

Publication number Publication date
ES2709489T3 (es) 2019-04-16
US20100311708A1 (en) 2010-12-09
EP2182954B1 (en) 2018-11-28
US20200101084A1 (en) 2020-04-02
TR201901012T4 (tr) 2019-02-21
EP2182954A1 (en) 2010-05-12
SI2182954T1 (sl) 2019-04-30
WO2009013334A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
GB0803018D0 (en) Therapeutic compounds and their use
SI1978947T1 (sl) Nitrooksiderivati za uporabo pri zdravljenju mišičnih distrofij
IL230683A0 (en) dpp-iv inhibitors for use in the treatment of nafld
GB0804685D0 (en) Therapeutic compounds and their use
PL2101731T3 (pl) Endoksyfen do zastosowania w leczeniu nowotworu
ZA201002764B (en) Benzodiazepinone compounds useful in the treatment of skin conditions
GB0817208D0 (en) Therapeutic apsap compounds and their use
GB0807609D0 (en) Therapeutic compounds and their use
PL1912650T3 (pl) Zastosowanie flibanseryny w leczeniu otyłości
EP2307052A4 (en) ANTI-BETA-2-MICROGLOBULIN AGENTS AND THEIR USE
IL218851A0 (en) Use of dimiracetam in the treatment of chronic pain
IL212672A (en) Cycloandesdepsipeptide compounds and their use in drug production
IL204668A0 (en) Use of sulfonyl - substituted 2 - sulfonylaminobenzoic acid n - phenylamides in the treatment of pain
GB0822486D0 (en) Compounds for use in the treatment of pain
ZA201108106B (en) Use of phthalimide derivatives in the treatment of diseases
SI2491005T1 (sl) Uporaba 4-(etil(dimetil)amonio)butanoata pri zdravljenju bolezni srca in oĺ˝ilja
IL201426A0 (en) Drug combination and its use in the treatment of muscle loss
GB0812913D0 (en) Therapeutic compounds and their use
SI2182954T1 (sl) Uporaba nor-žolčnih kislin pri zdravljenju arterioskleroze
IL216717A0 (en) USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES
GB0821594D0 (en) Improvements in or relating to the treatment of tissue damage
GB0802128D0 (en) Therapeutic compounds and their use
GB2466110B (en) Antibacterial formulation for use in the treatment of acne
GB0821539D0 (en) Therapeutic compounds and their use
GB0815134D0 (en) Therapeutic compounds and their use